These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1617499)

  • 21. Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogs.
    Li XJ; Jee WS; Li YL; Patterson-Buckendahl P
    Bone; 1990; 11(5):353-64. PubMed ID: 2252812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats.
    Lin BY; Jee WS; Ma YF; Ke HZ; Kimmel DB; Li XJ
    Bone; 1994; 15(5):489-96. PubMed ID: 7980959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin E2 prevents bone loss and adds extra bone to immobilized distal femoral metaphysis in female rats.
    Akamine T; Jee WS; Ke HZ; Li XJ; Lin BY
    Bone; 1992; 13(1):11-22. PubMed ID: 1581103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats.
    Ma YF; Jee WS; Ke HZ; Lin BY; Liang XG; Li M; Yamamoto N
    J Bone Miner Res; 1995 Mar; 10(3):496-505. PubMed ID: 7785472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancellous bone of aged rats maintains its capacity to respond vigorously to the anabolic effects of prostaglandin E2 by modeling-dependent bone gain.
    Cui L; Ma YF; Yao W; Zhou H; Setterberg RB; Liang TC; Jee WS
    J Bone Miner Metab; 2001; 19(1):29-37. PubMed ID: 11156470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
    Ma YF; Lin BY; Jee WS; Lin CH; Chen YY; Ke HZ; Li XJ
    J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariae.
    Suponitzky I; Weinreb M
    J Endocrinol; 1998 Jan; 156(1):51-7. PubMed ID: 9496233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous infusion of PGE2 is catabolic with a negative bone balance on both cancellous and cortical bone in rats.
    Tian XY; Zhang Q; Zhao R; Setterberg RB; Zeng QQ; Ma YF; Jee W SS
    J Musculoskelet Neuronal Interact; 2007; 7(4):372-81. PubMed ID: 18094515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin E2 adds bone to a cancellous bone site with a closed growth plate and low bone turnover in ovariectomized rats.
    Ma YF; Ke HZ; Jee WS
    Bone; 1994; 15(2):137-46. PubMed ID: 8086230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
    Ma YF; Pan Z; Jee WS; Lin CH; Liang HH; Chen H; Pun S; Li XJ
    J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Greater bone formation induction occurred in aged than young cancellous bone sites.
    Ke HZ; Jee WS; Ito H; Setterberg RB; Li M; Lin BY; Liang XG; Ma YF
    Bone; 1993; 14(3):481-5. PubMed ID: 8363896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E2 restores cancellous bone to immobilized limb and adds bone to overloaded limb in right hindlimb immobilization rats.
    Li M; Jee WS; Ke HZ; Liang XG; Lin BY; Ma YF; Setterberg RB
    Bone; 1993; 14(3):283-8. PubMed ID: 8363869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risedronate pretreatment does not hamper the anabolic effects of prostaglandin E2 in ovx rats.
    Li QN; Jee WS; Ma YF; Ke HZ; Xie H; Huang LF; Liang NC
    Bone; 1995 Oct; 17(4 Suppl):261S-266S. PubMed ID: 8579926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skeletal alterations in hypophysectomized rats: I. A histomorphometric study on tibial cancellous bone.
    Yeh JK; Chen MM; Aloia JF
    Anat Rec; 1995 Apr; 241(4):505-12. PubMed ID: 7604965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lumbar vertebral cancellous bone is capable of responding to PGE2 treatment by stimulating both modeling and remodeling-dependent bone gain in aged male rats.
    Zhou H; Ma YF; Yao W; Cui L; Setterberg R; Liang CT; Jee WS
    Calcif Tissue Int; 2001 Mar; 68(3):179-84. PubMed ID: 11351502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraosseous infusion of prostaglandin E2 in the caprine tibia.
    Welch RD; Johnston CE; Waldron MJ; Poteet B
    J Orthop Res; 1993 Jan; 11(1):110-21. PubMed ID: 8423513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat.
    Katz IA; Jee WS; Joffe II; Stein B; Takizawa M; Jacobs TW; Setterberg R; Lin BY; Tang LY; Ke HZ
    J Bone Miner Res; 1992 Oct; 7(10):1191-200. PubMed ID: 1456087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S-ketoprofen inhibits tenotomy-induced bone loss and dynamics in weanling rats.
    Zeng QQ; Jee WS; Ke HZ; Wechter WJ
    Bone Miner; 1993 Jun; 21(3):203-18. PubMed ID: 8400920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.